Xavier University of Louisiana.

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Xavier University of Louisiana. sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).

6 total trials 1 currently recruiting 3 completed upper quartile by trial count

Xavier University of Louisiana.: 6 sponsored US clinical trials, 1 recruiting.

Xavier University of Louisiana. sponsors 6 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 3 completed. The most-studied condition in this pipeline is Prediabetic State & High Risk Individuals on the Basis of Diabetes Risk Score, with 1 trials.

Upper-quartile sponsor footprint

Xavier University of Louisiana. sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

What is open in the Xavier University of Louisiana. pipeline

1 recruiting of 6 indexed (17% open); 3 completed (50%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Prediabetic State & High Risk Individuals on the Basis of Diabetes Risk Score (1 trial), 4 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Xavier University of Louisiana.: open-pipeline peers nationwide

Peers matched on 6 registered trials and 17% open enrollment, not the therapeutic-area sidebar.

Xavier University of Louisiana. sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 468101214 0%20%40%60%80% Total trials Recruiting share Xavier University of Louisiana.23andMeAardvark TherapeuticsAbbisko Therapeutics CoAbGenomics B.V Taiwan BranchAdageneAgendiaAkamis BioAngiodynamics
Xavier University of Louisiana. sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Xavier University of Louisiana. sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 6 trials (± recruiting share)

Sponsors near 17% open enrollment (± trial volume)

What to do with this Xavier University of Louisiana. page

6 registered trials is a research-attention snapshot, not an endorsement of Xavier University of Louisiana. or any single study.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Xavier University of Louisiana. pipeline card: 6 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.